698 related articles for article (PubMed ID: 29462027)
1. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
4. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
[TBL] [Abstract][Full Text] [Related]
6. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L
Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983
[TBL] [Abstract][Full Text] [Related]
8. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
Lv Y; He C; Wang Z; Guo W; Wang J; Bai W; Zhang L; Wang Q; Liu H; Luo B; Niu J; Li K; Tie J; Yin Z; Fan D; Han G
Radiology; 2017 Dec; 285(3):999-1010. PubMed ID: 28682164
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
Lakhoo J; Gaba RC
Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
[TBL] [Abstract][Full Text] [Related]
12. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.
Andring B; Kalva SP; Sutphin P; Srinivasa R; Anene A; Burrell M; Xi Y; Pillai AK
World J Gastroenterol; 2015 Jul; 21(26):8110-7. PubMed ID: 26185383
[TBL] [Abstract][Full Text] [Related]
13. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.
Thornburg B; Desai K; Hickey R; Kulik L; Ganger D; Baker T; Abecassis M; Lewandowski RJ; Salem R
Tech Vasc Interv Radiol; 2016 Mar; 19(1):52-60. PubMed ID: 26997089
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications.
Chen Y; Ye P; Li Y; Ma S; Zhao J; Zeng Q
Eur Radiol; 2015 Dec; 25(12):3431-7. PubMed ID: 25903717
[TBL] [Abstract][Full Text] [Related]
15. The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis.
Chinchilla-López P; Hamdan-Pérez N; Guerrero-Ixtlahuac J; Barranco-Fragoso B; Méndez-Sánchez N
Ann Hepatol; 2017; 16(4):619-620. PubMed ID: 28611269
[TBL] [Abstract][Full Text] [Related]
16. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.
Yang S; He C; Fan X; Ding W; Wu X; Li J
J Vasc Interv Radiol; 2015 Jul; 26(7):1009-17. PubMed ID: 25921970
[TBL] [Abstract][Full Text] [Related]
17. Utility of Transjugular Intrahepatic Portosystemic Shunt Placement for Maintaining Portal Vein Patency in Candidates on Wait Lists Who Develop Thrombus.
Alani M; Rowley M; Kang P; Chen S; Hirsch K; Seetharam A
Exp Clin Transplant; 2020 Dec; 18(7):808-813. PubMed ID: 31830878
[TBL] [Abstract][Full Text] [Related]
18. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.
Wang L; He F; Yue Z; Zhao H; Fan Z; Zhao M; Qiu B; Yao J; Lin Q; Dong X; Liu F
Sci Rep; 2017 Sep; 7(1):10868. PubMed ID: 28883536
[TBL] [Abstract][Full Text] [Related]
19. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy
Jiang TT; Luo XP; Sun JM; Gao J
World J Gastroenterol; 2017 Nov; 23(41):7470-7477. PubMed ID: 29151701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
